de Citadel Advisors Madrigal Pharmaceuticals MDGL Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 272 M | Comprar |
507,233
+53,390
| +12% | +USD 27.3 M | 0.03% | 410 |
|
|
2026
Q1 | USD 238 M | Comprar |
453,843
+417,709
| +1,156% | +USD 200 M | 0.04% | 381 |
|
|
2025
Q4 | USD 21 M | Vender |
36,134
-12,238
| -25% | -USD 6.25 M | ﹤0.01% | 2284 |
|
|
2025
Q3 | USD 22.2 M | Vender |
48,372
-158,967
| -77% | -USD 59.3 M | ﹤0.01% | 2204 |
|
|
2025
Q2 | USD 62.7 M | Comprar |
207,339
+206,538
| +25,785% | +USD 61.5 M | 0.01% | 1064 |
|
|
2025
Q1 | USD 265 k | Vender |
801
-14,071
| -95% | -USD 4.62 M | ﹤0.01% | 9858 |
|
|
2024
Q4 | USD 4.59 M | Vender |
14,872
-39,777
| -73% | -USD 11.2 M | ﹤0.01% | 4101 |
|
|
2024
Q3 | USD 11.6 M | Comprar |
54,649
+43,459
| +388% | +USD 11.1 M | ﹤0.01% | 2690 |
|
|
2024
Q2 | USD 3.13 M | Vender |
11,190
-13,422
| -55% | -USD 3.2 M | ﹤0.01% | 4509 |
|
|
2024
Q1 | USD 6.57 M | Comprar |
24,612
+14,120
| +135% | +USD 3.33 M | ﹤0.01% | 3542 |
|
|
2023
Q4 | USD 2.43 M | Vender |
10,492
-266,334
| -96% | -USD 46.6 M | ﹤0.01% | 5020 |
|
|
2023
Q3 | USD 40.4 M | Comprar |
276,826
+192,917
| +230% | +USD 36.3 M | 0.01% | 1254 |
|
|
2023
Q2 | USD 19.4 M | Vender |
83,909
-50,235
| -37% | -USD 13.6 M | ﹤0.01% | 1918 |
|
|
2023
Q1 | USD 32.5 M | Vender |
134,144
-36,143
| -21% | -USD 9.8 M | 0.01% | 1462 |
|
|
2022
Q4 | USD 49.4 M | Comprar |
170,287
+128,143
| +304% | +USD 12.5 M | 0.01% | 1132 |
|
|
2022
Q3 | USD 2.74 M | Vender |
42,144
-10,443
| -20% | -USD 726 k | ﹤0.01% | 4985 |
|
|
2022
Q2 | USD 3.76 M | Vender |
52,587
-6,865
| -12% | -USD 505 k | ﹤0.01% | 4333 |
|
|
2022
Q1 | USD 5.83 M | Vender |
59,452
-2,049
| -3% | -USD 173 k | ﹤0.01% | 3876 |
|
|
2021
Q4 | USD 5.21 M | Comprar |
61,501
+29,313
| +91% | +USD 2.41 M | ﹤0.01% | 4219 |
|
|
2021
Q3 | USD 2.57 M | Vender |
32,188
-128,807
| -80% | -USD 11.1 M | ﹤0.01% | 5743 |
|
|
2021
Q2 | USD 15.7 M | Vender |
160,995
-58,810
| -27% | -USD 6.96 M | ﹤0.01% | 2394 |
|
|
2021
Q1 | USD 25.7 M | Comprar |
219,805
+212,612
| +2,956% | +USD 24.8 M | 0.01% | 1675 |
|
|
2020
Q4 | USD 799 k | Vender |
7,193
-118,491
| -94% | -USD 14.5 M | ﹤0.01% | 7261 |
|
|
2020
Q3 | USD 14.9 M | Comprar |
125,684
+74,010
| +143% | +USD 8.04 M | ﹤0.01% | 1840 |
|
|
2020
Q2 | USD 5.85 M | Vender |
51,674
-19,771
| -28% | -USD 1.94 M | ﹤0.01% | 2877 |
|
|
2020
Q1 | USD 4.77 M | Comprar |
71,445
+29,836
| +72% | +USD 2.49 M | ﹤0.01% | 2767 |
|
|
2019
Q4 | USD 3.79 M | Vender |
41,609
-18,507
| -31% | -USD 1.79 M | ﹤0.01% | 3455 |
|
|
2019
Q3 | USD 5.18 M | Vender |
60,116
-46,509
| -44% | -USD 4.36 M | ﹤0.01% | 3065 |
|
|
2019
Q2 | USD 11.2 M | Comprar |
106,625
+93,462
| +710% | +USD 10 M | 0.01% | 2057 |
|
|
2019
Q1 | USD 1.65 M | Comprar |
13,163
+3,259
| +33% | +USD 405 k | ﹤0.01% | 4773 |
|
|
2018
Q4 | USD 1.12 M | Vender |
9,904
-2,310
| -19% | -USD 358 k | ﹤0.01% | 5141 |
|
|
2018
Q3 | USD 2.62 M | Comprar |
12,214
+728
| +6% | +USD 183 k | ﹤0.01% | 3957 |
|
|
2018
Q2 | USD 3.21 M | Vender |
11,486
-179,167
| -94% | -USD 31.5 M | ﹤0.01% | 3383 |
|
|
2018
Q1 | USD 22.3 M | Vender |
190,653
-190,674
| -50% | -USD 23.5 M | 0.01% | 1042 |
|
|
2017
Q4 | USD 35 M | Comprar |
+381,327
| Nuevas | +USD 21.8 M | 0.02% | 815 |
|
|
2016
Q4 | – | Vender |
-26,202
| Cerradas | -USD 332 k | – | 7606 |
|
|
2016
Q3 | USD 332 k | Vender |
26,202
-609
| -2% | -USD 5.9 k | ﹤0.01% | 5506 |
|
|
2016
Q2 | USD 244 k | Comprar |
26,811
+591
| +2% | +USD 7.09 k | ﹤0.01% | 5519 |
|
|
2016
Q1 | USD 220 k | Vender |
26,220
-8,638
| -25% | -USD 72.1 k | ﹤0.01% | 5522 |
|
|
2015
Q4 | USD 429 k | Comprar |
34,858
+34,739
| +29,192% | +USD 953 k | ﹤0.01% | 4676 |
|
|
2015
Q3 | USD 7 k | Vender |
119
-999
| -89% | -USD 72.1 k | ﹤0.01% | 8569 |
|
|
2015
Q2 | USD 87 k | Vender |
1,118
-4,938
| -82% | -USD 414 k | ﹤0.01% | 7219 |
|
|
2015
Q1 | USD 411 k | Comprar |
6,056
+106
| +2% | +USD 9.09 k | ﹤0.01% | 5219 |
|
|
2014
Q4 | USD 552 k | Comprar |
5,950
+4,746
| +394% | +USD 491 k | ﹤0.01% | 4597 |
|
|
2014
Q3 | USD 127 k | Vender |
1,204
-538
| -31% | -USD 74.8 k | ﹤0.01% | 6187 |
|
|
2014
Q2 | USD 249 k | Comprar |
1,742
+1,662
| +2,078% | +USD 243 k | ﹤0.01% | 5305 |
|
|
2014
Q1 | USD 12 k | Vender |
80
-4,465
| -98% | -USD 879 k | ﹤0.01% | 7461 |
|
|
2013
Q4 | USD 833 k | Comprar |
4,545
+3,500
| +335% | +USD 641 k | ﹤0.01% | 3407 |
|
|
2013
Q3 | USD 231 k | Vender |
1,045
-278
| -21% | -USD 59.1 k | ﹤0.01% | 4626 |
|
|
2013
Q2 | USD 231 k | Comprar |
+1,323
| Nuevas | +USD 345 k | ﹤0.01% | 4543 |
|
Otros fondos que tienen MDGL en su cartera
BBA
Posición de Citadel Advisors en MDGL: resumen de T2 2026
Citadel Advisors aumentó su participación en Madrigal Pharmaceuticals (MDGL) en 12% durante T2 2026, al comprar aproximadamente USD 27.3 M y elevar la posición a 507,233 acciones con un valor de USD 272 M. La posición representa 0.03% de la cartera y ocupa el puesto #410.
Citadel Advisors reportó por primera vez una posición en MDGL en T2 2013 y la ha mantenido durante 49 trimestres desde entonces. Al cierre de T2 2026, 414 fondos que sigue Wall St. Rank mantienen una posición en MDGL.
- Al cierre de T2 2026, Citadel Advisors tenía 507,233 acciones de Madrigal Pharmaceuticals con un valor de USD 272 M.
- Citadel Advisors compró 53,390 acciones de Madrigal Pharmaceuticals en T2 2026, por un monto estimado de USD 27.3 M.
- Madrigal Pharmaceuticals representó 0.03% de la cartera de Citadel Advisors en T2 2026 y fue su posición número 410.
- Citadel Advisors reportó por primera vez una posición en Madrigal Pharmaceuticals en T2 2013 y la ha mantenido durante 49 trimestres desde entonces.
- Al cierre de T2 2026, 414 fondos que sigue Wall St. Rank tenían Madrigal Pharmaceuticals en cartera.
Según el Informe 13F de Citadel Advisors correspondiente a T2 2026, presentado el 14 ago 2026.